Pruritus Therapeutics Market Experience important Growth during the Forecast Period 2019-2026
According to the current analysis
of Reports and Data, the global Pruritus Therapeutics market was
valued at USD 11.09 Billion in 2018 and is expected to reach USD 17.99 Billion
by year 2026, at a CAGR of 6.2 percent. The study covers therapeutic agents for
‘Pruritus’ - an unpleasant sensation that stimulates desire to scratch the
skin. Pruritus therapeutics are available in wide range of skin conditions and
other underlying causes of pruritus. Recent emergence of TRP channels as a drug
target for treatment of itching is a major disruptive finding in pruritus
sector. In line with this, TRP channel antagonists, TRPM8 agonists are some of
the emerging TRP channel modulation mechanisms that can be for could be used
for pruritus treatment.
Rising prevalence of target
diseases, unmet needs of pruritus patients pushing the drug development,
significant focus of pharmaceutical companies on development of novel
mechanisms based pruritus drugs, upcoming patent expiry, availability of
public as well private funds for research, and favorable regulatory scenario,
are some of the key factors propelling market growth in the industry. However,
associated side effects, and availability of advanced alternative treatment
options such as photo therapy, are the major hindrance for market growth during
2019-2026.
To identify the key trends in the industry, click on the
link below:
https://www.reportsanddata.com/report-detail/pruritus-therapeutics-market
https://www.reportsanddata.com/report-detail/pruritus-therapeutics-market
Further key findings from
the report suggest
- Pruritus Therapeutics market is growing at a CAGR of
1% in Asia Pacific followed by North America and Europe, with 6.1 % and
6.0% CAGR, respectively. High pruritus prevalence across the globe is the
key factor to accelerate the market growth during forecast period across
all regions.
- As of 2018, Corticosteroids is the dominating
pruritus therapeutics which holds 41.4% of the global market. European
regional market is the chief revenue generating source for this product
segment, followed by North America and Asia-Pacific regions.
- Calcineurin Inhibitors is expected to be the fastest
growing market segment during forecast period 2019-2026 with a CAGR of
6.9%. However, associated side effects and costs are major challenge for
the market growth of this market segment.
- Skin conditions disease type segment (that includes
xerosis, dermatitis, psoriasis, scabies, burns & scars, insect bites
and hives) . was valued at USD 7.60 billion and is expected reach USD
12.60 billion by 2026.
- Asia Pacific is expected to account for the 24.3% of
the global Pruritus therapeutics market. Developing nations such China,
and India are likely to witness high growth
- Associated side effects related to pruritus
therapeutics and lack of awareness about pruritus is likely to hinder the
market growth during the forecast period.
- Key participants include Allergan, Astellas Pharma,
Bristol-Myers Squibb, Cipla, Eli Lilly, GlaxoSmithKline, Merck, Novartis,
Pfizer, and Sanofi.
Request For Free PDF Sample Of This
Research Report At: https://www.reportsanddata.com/sample-enquiry-form/1176
For the purpose of this report,
Reports and Data has segmented the Pruritus Therapeutics market on the basis of
type, disease type, treatment type, end use, and region:
Type (Revenue, USD Million;
2016–2026)
- Corticosteroids
- Antihistamines
- Local Anesthetics
- Counterirritants
- Immunosuppressant
- Calcineurin Inhibitors
- Others
Disease Type (Revenue, USD
Million; 2016–2026)
- Skin conditions
- Atopic Dermatitis
- Allergic Contact Dermatitis
- Urticaria
- Others
- Internal diseases
- Nerve disorders
- Psychiatric diseases
- Irritation and allergic reactions
Treatment Type (Revenue, USD
Million; 2016–2026)
- Itchy skin treatment
- Corticosteroid creams and ointments
- Other creams and ointments
- Oral medications
End Use (Revenue, USD Million;
2016–2026)
- Hospital
- Clinic
- Others
Regional Outlook (Revenue in
USD Million; 2016–2026)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of the Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
- Brazil
Ask For Discount: https://www.reportsanddata.com/discount-enquiry-form/1176
Table Of Content
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018 – 2026
Chapter 3. Indicative Metrics
3.1. Rising prevalence of atopic dermatitis
3.2. Increasing incidences of allergic contact dermatitis
3.3. Global burden of diabetes
3.4. Worldwide cases of adverse drug reactions
Chapter 4. Pruritus Therapeutics Segmentation & Impact Analysis
4.1. Pruritus Therapeutics Segmentation Analysis
4.2. Pruritus Therapeutics Market Value Chain Analysis, 2016-2026
4.3. Regulatory framework
4.4. Pruritus Therapeutics Market Impact Analysis
4.4.1. Market driver analysis
4.4.1.1. High prevalence of target diseases across the world
4.4.1.2. Launch of novel therapeutics
4.4.2. Market restraint analysis
4.4.2.1. Lack of awareness
4.4.2.2. Availability of generics
4.5. Key opportunities prioritized
4.6. Pruritus Therapeutics Pricing Analysis
4.7. Industry analysis - Porter's
4.8. Pruritus Therapeutics PESTEL Analysis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018 – 2026
Chapter 3. Indicative Metrics
3.1. Rising prevalence of atopic dermatitis
3.2. Increasing incidences of allergic contact dermatitis
3.3. Global burden of diabetes
3.4. Worldwide cases of adverse drug reactions
Chapter 4. Pruritus Therapeutics Segmentation & Impact Analysis
4.1. Pruritus Therapeutics Segmentation Analysis
4.2. Pruritus Therapeutics Market Value Chain Analysis, 2016-2026
4.3. Regulatory framework
4.4. Pruritus Therapeutics Market Impact Analysis
4.4.1. Market driver analysis
4.4.1.1. High prevalence of target diseases across the world
4.4.1.2. Launch of novel therapeutics
4.4.2. Market restraint analysis
4.4.2.1. Lack of awareness
4.4.2.2. Availability of generics
4.5. Key opportunities prioritized
4.6. Pruritus Therapeutics Pricing Analysis
4.7. Industry analysis - Porter's
4.8. Pruritus Therapeutics PESTEL Analysis
Continue…
About
Reports and Data
Reports and Data is a market research
and consulting company that provides syndicated research reports, customized
research reports, and consulting services. Our solutions purely focus on your purpose
to locate, target and analyze consumer behavior shifts across demographics,
across industries and help client’s make a smarter business decision. We offer
market intelligence studies ensuring relevant and fact-based research across a
multiple industries including Healthcare, Technology, Chemicals, Power, and
Energy. We consistently update our research offerings to ensure our clients are
aware about the latest trends existent in the market. Reports and Data has a
strong base of experienced analysts from varied areas of expertise.
Contact Us:
John
Watson
Head of
Business Development
Reports
And Data | Web: www.reportsanddata.com
Direct
Line: +1-800-819-3052
E-mail:
sales@reportsanddata.com
Comments
Post a Comment